News Search Results
Oct 01, 2025, 09:00 ET CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES QUARTERLY CASH DIVIDEND
$0.08 per share quarterly cash dividend on its common stock and a corresponding $8.00 per share quarterly cash dividend on its Series D preferred stock. Each share of Series D preferred stock is convertible into 100 shares of common stock. The dividend is payable on October 21, 2025 to shareholders of
More news about: CF BANKSHARES INC.
Sep 26, 2025, 06:32 ET Weekly Recap: 11 Tech Press Releases You Need to See
AppZen Raises $180 Million Growth Round Led by Riverwood Capital to Take the Next Step in Autonomous Finance The Series D fundraise allows AppZen to further accelerate the adoption of agentic AI at the enterprise, converting standard operating procedures into configurable,
More news about: PR Newswire
Sep 25, 2025, 16:05 ET LightPath Technologies Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results
Preferred stock: Series D, $.01 par value, voting; 500,000 shares authorized; none issued and outstanding
More news about: LightPath Technologies
Sep 25, 2025, 07:00 ET $97M Series D Backed by Strategic Investors Across the Oncology Ecosystem Positions Thyme Care to Break Through Cancer Care's Biggest Bottlenecks
Thyme Care, the leading value-based cancer care enabler, today announced a $97M Series D fundraise from current investors
More news about: Thyme Care
Sep 24, 2025, 09:44 ET Nature's Miracle Holding Inc. ("NMHI") Raised $2 Million Through Convertible Preferred Shares Issuance
convertible preferred investment agreement with an Asia-based private investor. Nature's Miracle Holding Inc. issued 2,000 Series D Preferred Shares which can be converted into the Company's common stocks at $0.1180 per share (the closing price on
More news about: Nature's Miracle Holding Inc
Sep 24, 2025, 08:00 ET Lightstone Ventures Marks Year-to-Date 2025 Milestones for its Innovative Biotech and Medtech Portfolio Companies
million Series C round closed in April 2025Allay Therapeutics – $57.5 million Series D round closed in June 2025Shoulder Innovations – $40 million Series E round closed
More news about: Lightstone Ventures
Sep 23, 2025, 17:16 ET Saul Centers Declares Quarterly Dividends
previous quarter and the amount paid in the prior year's comparable quarter. The Company also declared quarterly dividends on (a) its 6.125% Series D Cumulative Redeemable Preferred Stock, in the amount of $0.3828125 per depositary share and (b) its 6.000% Series E
More news about: Saul Centers, Inc.
Sep 22, 2025, 09:00 ET AppZen Raises $180 Million Growth Round Led by Riverwood Capital to Take the Next Step in Autonomous Finance
billion in savings and enabling finance teams to reallocate up to two-thirds of their manual workload to higher-value activities. The Series D fundraise allows AppZen to further accelerate the adoption of agentic AI at the enterprise, converting standard operating procedures into configurable,
More news about: AppZen
Sep 17, 2025, 06:00 ET Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
(the "Board") has declared a monthly cash dividend of $0.2708333 per share of the Company's outstanding 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock. The record date for this dividend is September 30, 2025, and the payment
More news about: Hyperscale Data Inc.
Sep 17, 2025, 04:53 ET XTransfer and SPD Bank Shanghai Branch Enter Strategic Partnership Agreement
world, allowing SMEs to enjoy the same level of cross-border financial services as large multinational corporations. XTransfer completed its Series D financing in September 2021 and achieved unicorn status. The company has a diverse composition of international investors,
More news about: XTransfer
Sep 15, 2025, 16:15 ET ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
October 30, 2025, to holders of record on October 1, 2025. The Company will also pay a cash dividend on its 7.875% Series D Cumulative Redeemable Preferred Stock in the amount of $0.4921875 per share. The dividend will be payable on October
More news about: ACRES Commercial Realty Corp.
Sep 12, 2025, 10:00 ET Apex Raises $200 Million Series D Financing
/PRNewswire/ -- Apex, a leading spacecraft manufacturer of mass-produced productized, configurable satellite bus platforms, announced its $200 million Series D funding round led by Interlagos, boosting the company's valuation over one billion dollars.
More news about: Apex Space
Sep 11, 2025, 16:01 ET AGNC Investment Corp. Declares Third Quarter Dividends on Preferred Stock
$0.61911 6.875% Series D Fixed-to-Floating Rate
More news about: AGNC Investment Corp.
Sep 10, 2025, 16:15 ET Farmer Mac Declares Dividend on Series H Preferred Stock
declared dividends on the company's three classes of common stock (Class A, Class B, and Class C) and four other series of outstanding preferred stock (Series D, Series E, Series F, and Series G), which was announced on August 14, 2025.
More news about: Farmer Mac
Sep 04, 2025, 11:00 ET Juniper Square Announces Strategic Investment From Nasdaq Ventures to Accelerate Innovation in Private Markets Technology
$130 million Series D financing announced in June.
More news about: Juniper Square
Sep 03, 2025, 03:00 ET ViCentra Raises $85M to Scale Manufacturing and Accelerate Market Penetration of Kaleido Insulin Patch Pump
redefining insulin delivery for people with diabetes, today announced the successful close of an upsized $85 million Series D financing led by new investor Innovation Industries, a leading
More news about: ViCentra
Aug 27, 2025, 09:00 ET Persona Named a Leader in the 2025 Gartner® Magic Quadrant™ for Identity Verification
$200M Series D at a $2B valuation to build the verified identity layer for an agentic AI world. Looking ahead,
More news about: Persona
Aug 25, 2025, 17:31 ET Crohn's Disease Market Projected to Grow at 4.3% CAGR (2020-2034), Driven by Improved Diagnosis, Pediatric Label Expansion, and New Second-line Therapies | DelveInsight
potential as a therapeutic target. In October 2024, the company raised USD 89 million in a Series D round, with participation from new investors including Sanofi and Invus, along with support from existing backers. In May 2025,
More news about: DelveInsight Business Research, LLP
Aug 21, 2025, 16:05 ET Merchants Bancorp Declares Quarterly Common and Preferred Dividends
$20.625 per share (equivalent to $0.5156 per depositary share) on the Company's outstanding shares of its 8.25% Series D preferred stock (NASDAQ: MBINM).A dividend of $19.06 per share (equivalent to $0.4765
More news about: Merchants Bancorp
Aug 20, 2025, 07:02 ET Group14 Closes US$463M Series D Funding Round and Acquires 100% Ownership of BAM Factory in South Korea from SK, Inc.
SK leads Series D to accelerate the scale and global delivery of SCC55®.Group14 also acquires the 75% balance of the South Korea joint venture with SK, taking direct control over the manufacture of the company's silicon battery material
More news about: Group14 Technologies
Aug 15, 2025, 06:30 ET Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
(the "Board") has declared a monthly cash dividend of $0.2708333 per share of the Company's outstanding 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock. The record date for this dividend is August 31, 2025, and the payment
More news about: Hyperscale Data Inc.
Aug 14, 2025, 16:15 ET Farmer Mac Declares Quarterly Dividends on Common and Preferred Stock
four classes of preferred stock. The quarterly dividend of $0.35625 per share of 5.700% Non-Cumulative Preferred Stock, Series D (NYSE: AGM.PR.D), $0.359375 per share of 5.750% Non-Cumulative Preferred Stock, Series E (NYSE: AGM.PR.E), $0.328125
More news about: Farmer Mac
Aug 12, 2025, 16:05 ET Caris Life Sciences Reports Second Quarter 2025 Financial Results
(177,214) Deemed dividend from Series D redeemable convertible preferred stock (384,436)
More news about: Caris Life Sciences
Aug 12, 2025, 13:33 ET Conformal Medical Closes $32 Million Series D Extension to Advance its Next-Generation Left Atrial Appendage Occlusion Technology
Inc., a medical device company developing next-generation left atrial appendage occlusion (LAAO) technology, announced the successful closing of its Series D extension financing, with a new partner joining inside investors to raise a total of $32 million.
More news about: Conformal Medical, Inc.
Aug 12, 2025, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update
$65.00 per share (iii) series C warrants to purchase 66,667 shares of Common Stock at $65.20 per share and (iv) series D warrants to purchase 66,667 shares of Common Stock at $65.20 per share, originally issued in July
More news about: Acurx Pharmaceuticals, Inc.